company background image
AMBEEPHA logo

Ambee Pharmaceuticals DSE:AMBEEPHA Stock Report

Last Price

৳745.30

Market Cap

৳1.8b

7D

-0.4%

1Y

-3.8%

Updated

31 Jan, 2025

Data

Company Financials

Ambee Pharmaceuticals PLC

DSE:AMBEEPHA Stock Report

Market Cap: ৳1.8b

AMBEEPHA Stock Overview

Engages in the manufacture and sale of pharmaceuticals, chemicals, medicals, and other preparations in Bangladesh. More details

AMBEEPHA fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance3/6
Financial Health5/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Ambee Pharmaceuticals PLC Competitors

Price History & Performance

Summary of share price highs, lows and changes for Ambee Pharmaceuticals
Historical stock prices
Current Share Price৳745.30
52 Week High৳1,002.70
52 Week Low৳650.00
Beta-0.20
1 Month Change4.62%
3 Month Change-11.75%
1 Year Change-3.80%
3 Year Change55.73%
5 Year Change56.31%
Change since IPO4,607.16%

Recent News & Updates

Recent updates

Shareholder Returns

AMBEEPHABD PharmaceuticalsBD Market
7D-0.4%-3.1%-0.8%
1Y-3.8%-30.6%-17.7%

Return vs Industry: AMBEEPHA exceeded the BD Pharmaceuticals industry which returned -30.7% over the past year.

Return vs Market: AMBEEPHA exceeded the BD Market which returned -17.7% over the past year.

Price Volatility

Is AMBEEPHA's price volatile compared to industry and market?
AMBEEPHA volatility
AMBEEPHA Average Weekly Movement3.9%
Pharmaceuticals Industry Average Movement5.2%
Market Average Movement5.0%
10% most volatile stocks in BD Market7.0%
10% least volatile stocks in BD Market2.8%

Stable Share Price: AMBEEPHA has not had significant price volatility in the past 3 months compared to the BD market.

Volatility Over Time: AMBEEPHA's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1976529Kazi Ferdouswww.ambeepharma.com

Ambee Pharmaceuticals PLC engages in the manufacture and sale of pharmaceuticals, chemicals, medicals, and other preparations in Bangladesh. The company offers products in various therapeutic areas, including analgesic and antipyretic, anti-helmintic, antacid, anti-histamine, anti-protozoal, anti-fungal, antiasthmatic and antitussive, antibacterial, anticonvulstant, antiemetic, antihypertensive, antilipidemic agents, antiosteoarthritic, antispasmodic, antituberculer, antiulcerant, anxiolytic and hypnotic, cerebral vasodilator, corticosteroid drugs, diuretic agents, non-steroidal anti-inflammatory, steroidal anti-inflammatory drugs, haematinic, and vitamins and minerals. It also provides its products in form of tablets, capsules, liquids, tubes, and injections.

Ambee Pharmaceuticals PLC Fundamentals Summary

How do Ambee Pharmaceuticals's earnings and revenue compare to its market cap?
AMBEEPHA fundamental statistics
Market cap৳1.79b
Earnings (TTM)৳9.95m
Revenue (TTM)৳226.30m

179.7x

P/E Ratio

7.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
AMBEEPHA income statement (TTM)
Revenue৳226.30m
Cost of Revenue৳106.07m
Gross Profit৳120.23m
Other Expenses৳110.28m
Earnings৳9.95m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)4.15
Gross Margin53.13%
Net Profit Margin4.40%
Debt/Equity Ratio0%

How did AMBEEPHA perform over the long term?

See historical performance and comparison

Dividends

0.1%

Current Dividend Yield

24%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/31 14:06
End of Day Share Price 2025/01/30 00:00
Earnings2024/12/31
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Ambee Pharmaceuticals PLC is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution